Molecular Partners Ag (MOLN) Cash from Investing Activities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Cash from Investing Activities for 7 consecutive years, with -$5016.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 112.9% year-over-year to -$5016.1; the TTM figure through Mar 2026 stood at $88.6 million (up 98.04% YoY), while the FY2025 annual figure was $90.8 million, up 96.41% from the prior year.
• Cash from Investing Activities declined to -$5016.1 in Q1 2026 per MOLN's latest filing, from $90.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $113.3 million in Q3 2022 and bottomed at -$113.7 million in Q2 2022.
• Historically, Cash from Investing Activities has averaged $4.6 million across 5 years, with a median of $20176.6 in 2024.
• On a YoY basis, Cash from Investing Activities climbed as much as 1175.75% in 2022 and fell as far as 22331.61% in 2022.
• Molecular Partners Ag's Cash from Investing Activities stood at -$104.8 million in 2022, then surged by 147.98% to $50.3 million in 2023, then retreated by 8.21% to $46.2 million in 2024, then surged by 96.46% to $90.7 million in 2025, then sank by 100.01% to -$5016.1 in 2026.
• Business Quant data shows MOLN's Cash from Investing Activities at -$5016.1 in Q1 2026, $90.7 million in Q4 2025, and -$62.3 million in Q3 2025.